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Rhamnolipids are multipurpose surface-active
molecules produced by the bacteriumPseudomonas
aeruginosa from L-rhamnose and R-3-hydroxyalka-
noate (C10±2) precursors. R-3-hydroxyalkanoate
precursor is believed to be synthesized de novo.
We demonstrate, however, that b-oxidation is the
predominant source of this precursor. Inhibition of
b-oxidation sharply decreases rhamnolipids produc-
tion, even when using a nonfatty acid carbon source
(glycerol). Isotope tracing shows that b-oxidation
intermediates are direct precursors of rhamnolipids.
A mutant-based survey revealed an operon coding
for enoyl-CoA hydratases/isomerases (ECH/I),
named RhlYZ, implicated in rhamnolipids production
via an axial role in 3-hydroxyalkanoate synthesis.
In vitro, RhlZ is an R-ECH/I transforming 2-dece-
noyl-CoA, a b-oxidation intermediate, into R-3-hy-
droxydecanoyl-CoA, the potential rhamnolipids
precursor. Interestingly, polyhydroxyalkanoates
share with rhamnolipids the RhlYZ-generated R-3-
hydroxyalkanoates pool, as demonstrated by the
decrease of polyhydroxyalkanoates upon mutation
of rhlYZ and the increase of rhamnolipids in a polyhy-
droxyalkanoates-defective mutant.
INTRODUCTION
The bacterium Pseudomonas aeruginosa is the best-studied
producer of rhamnolipids (RLs), surface-active, multipurpose
amphiphilic molecules (Abdel-Mawgoud et al., 2010). RLs are
produced as mixtures of congeners composed of one or two
rhamnose moieties linked to a dimer of R-3-hydroxy fatty acids
with chain lengths of C10±2 (De´ziel et al., 2000). Given the
biotechnological importance of RLs, much effort is dedicated
to maximize the production via optimization of culture condi-
tions (Abdel-Mawgoud et al., 2011). Nonetheless, higher yields
are still needed for an economically feasible industrial produc-
tion. It is becoming obvious that this can only be achieved via
metabolic engineering, which requires an exquisite understand-
ing of the metabolic regulation of RLs (Abdel-Mawgoud et al.,
2011).156 Chemistry & Biology 21, 156–164, January 16, 2014 ª2014 ElsevRLs are synthesized from two precursors, R-3-hydroxy fatty
acids and L-rhamnose, by the actions of three enzymes: RhlA,
RhlB, and RhlC. RhlA dimerizes R-3-hydroxy fatty acids forming
congeners of R-3-((R-3-hydroxyalkanoyl)oxy)alkanoic acids
(HAAs); the most abundant of which in P. aeruginosa is C10-
C10 (De´ziel et al., 2003; Zhu and Rock, 2008). The rhamnosyl
transferases RhlB and RhlC catalyze the sequential addition of
the first and second rhamnose to the C10-C10 dimer, forming
mono-RL (Rha-C10-C10) and di-RL (Rha-Rha-C10-C10), respec-
tively (Ochsner et al., 1994; Rahim et al., 2001). The focus of
the present study is to investigate the in vivo metabolic pathway
providing the RLs fatty acid precursors.
The exact lipid precursor of RLs is still unidentified, as the two
sole previous in vitro biochemical studies that explored this
precursor have reached different conclusions (Burger et al.,
1963; Zhu and Rock, 2008). Based on the study performed using
crude RhlA extracts, coenzyme A (CoA)-activated 3-hydroxy
fatty acids were concluded as precursors of HAAs (Burger
et al., 1963). Recently, however, acyl carrier protein (ACP)-acti-
vated 3-hydroxy fatty acids were shown, using purified RhlA, to
act instead as precursors, although without ruling out their
CoA-activated counterparts as possible precursors too (Zhu
and Rock, 2008). Because ACP-activated 3-hydroxy fatty acids
are intermediates of the de novo fatty acid synthase pathway
(FAS-II), it was hypothesized that FAS-II is the pathway providing
the lipid precursors of RLs (Zhu and Rock, 2008). Moreover, 3-
hydroxy fatty acids of RLs and their corresponding 3-hydrox-
yacyl-ACP intermediates of FAS-II share an R-configuration at
the chiral b-carbon bearing the 3-hydroxyl group, whereas the
corresponding 3-hydroxyacyl-CoAs intermediates produced
from the b-oxidation pathway are in the S-form (Zhu and Rock,
2008). However, very recently, the indirect implication of b-oxida-
tion in RLs biosynthesis was evoked when odd chain fatty acid-
containing RLs were produced upon feeding P. aeruginosa with
odd fatty acids (Hori et al., 2011) andwhen labeled RLswere pro-
duced upon feeding with labeled fatty acids (Zhang et al., 2012).
In the present study, we investigated the contribution of
b-oxidation as the direct metabolic source of 3-hydroxy fatty
acid precursors for RLs biosynthesis using specific inhibitors
of b-oxidation along with isotope tracing experiments. We
deciphered the channeling route between b-oxidation and RLs
biosynthesis using in vivo and in vitro approaches. We also
show the contribution of this channeling route on polyhydroxy-
alkanoates (PHA), an intracellular polymeric product composed
also of R-3-hydroxy fatty acids building blocks, and the impact
of blocking PHA production on RLs biosynthesis.ier Ltd All rights reserved
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Figure 1. Specific Inhibitors of b-Oxidation Decrease RLs Produc-
tion
(A) Dose-dependent inhibition of RLs and HAA production by 2-bromoocta-
noic acid.
(B) 2-Bromohexanoate similarly inhibits RLs production at equivalent molar
concentration (5 mM). Strain PA14 was grown in MSM-glycerol for 3 days at
34C. Data represent the mean of triplicate experiments ± SD.
See also Figures S1 and S2.
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Inhibition of b-Oxidation Decreases RLs Production
The implication of b-oxidation on RLs biosynthesis in
P. aeruginosa was investigated using specific b-oxidation inhib-
itors. This was conducted in amineral salts medium (MSM) using
glycerol as a sole carbon source and not a fatty acid source,
which is naturally demanding b-oxidation for assimilation and
growth. The b-oxidation inhibitors tested were acrylic, 4-pente-
noic and 2-bromooctanoic acids. Strikingly, at this carbon
source condition (glycerol), 2-bromooctanoic acid (2-Br-C8)
reduced RLs production by 50% and the lipid precursor HAA
by 80% (Figure S1A available online), whereas the other inhibi-
tors had no effect (Figure S1B).
To explore the specificity of 2-Br-C8 in RLs inhibition, the
dose-dependency of 2-Br-C8-mediated inhibition of RLs
production was examined.Moreover, the chain length specificity
of this inhibitory activity was also studied using shorter (2-Br-C4
and 2-Br-C6) and longer (2-Br-C12) homologs at equivalent molar
concentrations. The results show that 2-Br-C8 inhibits RLs and
HAA production in a dose-dependent manner (Figure 1). Surpris-
ingly, 2-Br-C6 (5 mM), not previously reported as a b-oxidation
inhibitor, also inhibits RLs production to the same extent as 2-Chemistry & Biology 21, 156Br-C8 (5 mM) (Figure 1B). The other congeners, 2-Br-C4 and 2-
Br-C12, caused considerable growth inhibition down to 3 mM.
Besides acting as an inhibitor of b-oxidation (Raaka and Low-
enstein, 1979), 2-Br-C8 was previously hypothesized to inhibit
PhaG, which transacylates the FAS-II intermediate R-3-hydrox-
yacyl-ACP to the CoA counterpart for PHA biosynthesis (Lee
et al., 2001). To rule out the hypothesis that PhaG product could
act as precursor for RLs biosynthesis and that the inhibition of
RLs production by 2-Br-C8 is caused by its effect on PhaG (Fig-
ure S2A), we tested RLs production in a phaG knockout as well
as a transposon insertion phaG mutant. Neither of the two mu-
tants affects RLs production (Figure S2B), excluding a role of
PhaG in the 2-Br-C8-mediated reduction of RLs production.
b-Oxidation Is the Main Source of Lipid Precursors for
RLs
To further evaluate the relative contribution of b-oxidation versus
FAS-II in RLs synthesis, strain PA14was cultivated inMSMusing
dodecanoic-12,12,12-d3 acid as the sole carbon source. Impli-
cation of either pathway was traced and estimated via examina-
tion of the pattern and extent of labeling of the HAA (C10-C10)
moiety of RLs produced. If RLs are labeled with three extra Dal-
tons per chain, this would entail that decanoic-12,12,12-d3 inter-
mediate of b-oxidation is incorporated as the lipid chains of RLs
(Figure S3A). Alternatively, if de novo fatty acid synthesis (FAS-II)
is predominantly implicated, produced RLs would be mostly un-
labeled as their chains would be de novo synthesized from the
more abundant unlabeled acetyl-CoA (five unlabeled versus
one labeled) units released after complete b-oxidation of dodec-
anoic-12,12,12-d3 acid (Figure S3A).
Strikingly, the RLs produced, which consisted solely of mono-
RLs, were almost exclusively (>99%) deuterium-labeled with
88% having an extra mass of 6 Da, ([M-H] mass-to-change
[m/z] 509) and 12% with an extra mass of 3 Da, ([M-H] m/z
506). Tandem mass spectrometry (MS/MS) fragmentation of
m/z 509 confirmed that the extra 6 Da were distributed equally
in the two lipid chains of RLs, 3 Da per chain (Figure S3B) and
thus corresponding to Rha-C10(d3)-C10-(d3). This clearly demon-
strates that b-oxidation is the main supplier of the lipid precursor
of RLs when fatty acids are the sole carbon source.
b-Oxidation Is Directly Linked to RLs Pathway
Using perdeuterooctadecanoic acid (C18-d35) and glucose as
cosubstrate, Zhang et al. (2012) suggested that the fatty acid
substrates of RLs are shortened via b-oxidation to the C8 chain
length after which one C2-elongation step via FAS-II takes place
before diversion of corresponding FAS-II C10-intermediate to
RLs biosynthesis (Zhang et al., 2012). However, our isotope
tracing experiments using dodecanoic-12,12,12-d3 acid are
suggesting instead a direct link between b-oxidation and RLs
biosynthesis. We thus verified the contribution of the hypothesis
of Zhang et al. (2012) in the supply of RLs lipid precursors relative
to b-oxidation. We fed PA14 with pandeuterododecanoic acid
(C12-d23) as sole carbon source. If b-oxidation is solely impli-
cated, each 3-hydroxydecanoate chain of RLs would be labeled
with an extra 17 Da (Figure S4A). On the other hand, if FAS-II is
implicated according to themodel of Zhang et al. (2012), the fatty
acid chain of RLs would bear an extra 16 Da (67%) or 15 Da
(33%) as the main species (Figure S4B).–164, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 157
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Figure 2. RhlY and RhlZ Are Implicated in RLs Biosynthesis by
Controlling the Supply of Lipid Precursors
(A) Deletion mutants, DrhlYZ and DrhlZ have similarly reduced RLs production.
Complementation of DrhlYZ with rhlZ only partially restores RLs production.
(B) RhlYZ is the main supplier of 3-hydroxyalkanoates (C10±2) in PA14. WT
PA14 strain and mutants were grown for 3 days in MSM-glycerol at 34C.
Lipids were analyzed by GC/MS. Data represent the mean of triplicate
experiments ± SD.
See also Figure S6 and Table S3.
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b-Oxidation Provides Precursors of RhamnolipidsInterestingly, using C12-d23 as the sole carbon source gener-
ated of 3-hydroxydecanoate bearing +17 Da as the species
of the highest abundance, whereas those bearing +16 Da
and +15 Da only represented 43% and 26% of the intensity of
the +17 Da species, respectively. The abundance of the +16 Da
and +15 Da species relative to each other were 62% and
38% respectively, which are close to theoretical predictions
mentioned above (Figure S5A). These results demonstrate that,
when using dodecanoic acid as sole carbon source, the majority
(60%) of the RLs lipidic precursors is directly supplied from
b-oxidation without resorting to a bypass through FAS-II.
To further investigate the hypothesis of Zhang et al. (2012), we
provided C12-d23 (3.75 g/l) together with glucose (10 g/l) as
cocarbon sources. Unexpectedly, due to a possible hydrogen-
deuterium isotopic negative metabolic effect, glucose was pref-
erentially utilized resulting in the formation of almost exclusively
unlabeled 3-hydroxydecanoate (95%) (Figure S5B). To over-
come this effect, we fed the bacterium with an excess of
glucose-13C6 (15 g/l) (83 mM) together with dodecanoate-158 Chemistry & Biology 21, 156–164, January 16, 2014 ª2014 Elsev12,12,12-d3 (30 mM) or tetradecanoate-14,14,14-d3 (30 mM).
Under these conditions, if b-oxidation is solely involved, the lipid
chains of RLs would bear an extra 3 Da each. However, if FAS-II
is implicated in the C2-elongation step (mostly with labeled
13C2)
of the C8-d3 intermediate according to the Zhang et al. (2012)
hypothesis, the lipid chains of RLs would bear an extra 5 Da
instead. The 2 extra Da in this case arises from the FAS-II-
mediated condensation of 13C2-labeled malonate units mostly
originating from glucose-13C6. Strikingly, under these condi-
tions, 3-hydroxydecanoate predominantly bore an extra 3 Da
only and minor amounts with extra 4 Da or 5 Da labeling (Figures
S5C and S5D), implying its direct b-oxidation origin.
Taken together, our results indicate that, whether fatty acids
are provided alone or as cocarbon sources with glucose,
b-oxidation remains the main direct supplier of lipid precursors
for RLs biosynthesis.
Enoyl-CoA Intermediates of b-Oxidation Are Diverted to
RLs Biosynthesis
Involvement of b-oxidation implicates that one of its inter-
mediates, namely, trans-2-enoyl-CoA, S-3-hydroxyacyl-CoA or
3-ketoacyl-CoA, is converted via an enoyl-CoA hydratase, an
epimerase, or a 3-ketoacyl-CoA reductase, respectively, into R-
3-hydroxy fatty acids, theultimate lipidprecursor ofRLs. Tofigure
out this b-oxidation intermediate, RLs production was examined
in mutants defective in enzymes carrying out these conversions.
A survey of the P. aeruginosa PA14 genome (Winsor et al.,
2011) for genes that might code for such enzymes revealed 14
loci predicted to encode enoyl-CoA hydratases (ECH) (Table
S3), while no putative epimerases or 3-ketoacyl-CoA reductases
were found. We also included in our survey the PHA-related
ECH, PhaJ1-4 (Tsuge et al., 2003). RLs productions in trans-
poson (Tn) or knockout (KO) mutants of 12 of these 14 ECH-cod-
ing loci were tested. Transposon mutants of phaJ2 and phaJ4
had no negative effect on RLs production (Figure S6A). Interest-
ingly, three putative enoyl-CoA hydratases/isomerases (ECH/I)
mutants, PA14_40980 (Tn), PA14_54640 (Tn), and PA14_54660
(KO) were associated with remarkable 35%, 56%, and 54% re-
ductions in RLs productions, respectively (Figure S6B). Because
of their impact on RLs biosynthesis, they were named rhlK, rhlY,
and rhlZ, respectively.
We focused on rhlY and rhlZ, as their corresponding mutants
were the most affected in RLs production. These two genes
are arranged in a single computationally predicted operon with
rhlZ downstream to rhlY (Winsor et al., 2011). To exclude the
possibility that the RLs phenotype associated with the rhlY trans-
poson mutant (Tn) is ultimately caused by a polar effect on its
downstream gene rhlZ, a double rhlYZ knockout mutant (KO)
was constructed and its RLs production was compared to that
of the simple rhlZ knockout mutant. In addition, rhlZ was
expressed in trans from a multicopy plasmid in both mutants.
Interestingly, the double knockout did not cause further
decrease in RLs production. Complementation with rhlZ
completely restored RLs production in the simple rhlZ mutant,
whereas, it only partially complemented RLs production in the
double rhlYZ mutant (Figure 2A). Moreover, overexpression of
rhlZ in the wild-type (WT) did not increase RLs production (Fig-
ure S6C). Collectively, these results demonstrate a direct role
for rhlZ in RLs production and, more interestingly, that RhlY isier Ltd All rights reserved
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Figure 3. RhlZ Is an R-Specific ECH/I Requiring RhlY for Its Activity
(A and B) The purified RhlZ alone did not catalyze any 3-hydroxydecanoate
formation from trans-2-decenoyl-CoA, therefore (A) total cell lysate of WT
was added in conjunction with purified RhlZ (Figure S7) and this caused
enrichment of the R-3-hydroxydecanoate compared to the total cell lysate
of WT alone that produced a nearly racemic mixture of R-/S-3-hydrox-
ydecanoate as shown in (B).
(C and D) The same was observed with total cell lysate of the mutant DrhlZ.
(E and F) The factor in lysates of WT or rhlZ mutant that is indispensable for
RhlZ activity appears to be RhlY as pure RhlZ does not produce any
3-hydroxydecanoate in the presence of total cell lysate of DrhlYZ. R/S-3-
hydroxydecanoate was analyzed using a chiral HPLC-MS/MS method.
Chemistry & Biology
b-Oxidation Provides Precursors of Rhamnolipids
Chemistry & Biology 21, 156simultaneously required with RhlZ to attain WT level of RLs
production.
The ECH/I RhlY and RhlZ Are Main Suppliers of
3-Hydroxydecanoate/Octanoate Pools
To experimentally confirm the putative ECH/I role assigned to
RhlY and RhlZ in the production of the 3-hydroxyalkanoate pre-
cursors of RLs, we compared the total intra- and extracellular
pool of 3-OH-C10±2 in the mutants and WT (Figure 2B). In agree-
ment with their putative function, both the single DrhlZ and more
markedly the double DrhlYZ knockouts presented a reduction of
3-OH-C10±2, more pronouncedly of 3-OH-C10 species followed
by 3-OH-C8 then 3-OH-C12 (Figure 2B). This remarkable
decrease in 3-hydroxy fatty acids precursors is in correlation
with the RLs reduction in these mutants (Figure 2A). Moreover,
these results demonstrate a pivotal metabolic role for RhlY/
RhlZ in the biosynthesis of 3-OH-alkanoates in P. aeruginosa
in general. Again, rhlZ complementation in the double mutant
only partially restored the WT level of 3-hydroxy fatty acid,
supporting oncemore the hypothesis that RhlY is simultaneously
required with RhlZ to attain the WT level of 3-hydroxy fatty acids
precursors and hence RLs.
RhlZ Is an R-Specific ECH/I
We hypothesized that RhlZ is an R-specific ECH/I (R-ECH/I)
converting a 2-decenoyl-CoA intermediate of b-oxidation into
the corresponding R-3-hydroxydecanoyl-CoA precursor of RLs
(Figure S2A). This was verified in vitro using purified RhlZ
(Figure 3) and trans-2-decenoyl-CoA as substrate. The relative
proportion of the R-stereoisomers and S-stereoisomers of 3-hy-
droxydecanoyl-CoA (3-OH-C10-CoA) produced was estimated
using a chiral high-performance liquid chromatography
(HPLC)-MS/MS method.
Purified RhlZ alone did not catalyze the formation of 3-hydrox-
ydecanoate from trans-2-decenoate. However, clarified cell
lysate of WT PA14 strain did convert trans-2-decenoate to
3-hydroxydecanoate at 0.53 mg/l (SD: ±0.016) where the R-iso-
mer was produced at 0.3 mg/l (SD: ±0.015) and the S-isomer at
0.23 mg/l (SD: ±0.012), i.e., at nearly racemic mixture of enantio-
mers (Figures 4 and 3B). Interestingly, combination of purified
RhlZ with a clarified WT cell lysate caused an1.5-fold increase
in the total yield of 3-hydroxydecanoate (0.75 mg/l, SD: ±0.003)
of which the R-isomer (0.61 mg/l, SD: ±0.004) was at least 4-fold
more abundant than the S-isomer (0.14 mg/l, SD: ±0.007) (Fig-
ures 4 and 3A). This demonstrates that RhlZ is indeed an R-
ECH/I, but it requires an unknown factor present in the WT cell
lysate. We hypothesized that this factor is a protein because
heat treatment of the clarified cell lysate abolished any RhlZ
activity with no any 3-hydroxydecanoate produced. According
to our previous data (Figure 2), this heat-sensitive factor was
likely RhlY. To verify this, we combined purified RhlZ with the
clarified cell lysates of DrhlYZ or DrhlZ. Consistent with our
hypothesis, the R-3-OH-C10 enrichment was conserved when
purified RhlZ was combined with the lysate of DrhlZ (Figures
3C and 3D), whereas no such enrichment was observed when
this purified RhlZ was combined with the lysate of the double
mutant DrhlYZ (Figures S3E and S3F).
The dependency of RhlZ on RhlY suggested a sort of inter-
action or complex formation. This was verified by a pull down–164, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 159
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Figure 5. SDS-PAGE of the Pull-Down Assay Showing the Stable
Physical Protein-Protein Interaction between RhlY and RhlZ
Purified his6-tagged RhlZ wasmixed with total cell lysate of WT PA14 strain for
1 hr at 4C, the mixture was then subjected to Nickel affinity chromatographic
purification using the same gradient of imidazole as previously done for puri-
fication of RhlZ (Figure S7A). Lane 1 is the purified RhlZ-His6 alone (bait). Lane
2 is the control lysate that was not exposed to the RhlZ-His6. Lane 3 is the
purified protein-RhlZ-His6 interaction; this protein was shown to be RhlY as
shown from its size compared to the purified RhlY-His6 in lane 4 (see also
Figure S7B) as well as by protein sequencing.
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Figure 4. RhlZ Is an R-Specific ECH/I and Is Specifically Inhibited by
a Metabolite of 2-Br-C8
In in vitro enzymatic assays in the presence of WT cell lysate, purified RhlZ
(Figure S7) causes R-specific enrichment of 3-hydroxydecanoate, and this
enrichment is blocked when usingWT lysate of cells cultivated in the presence
of 5 mM 2-Br-C8. R/S-3-hydroxydecanoate was analyzed using chiral HPLC-
MS/MS. Data represent the mean of triplicate experiments ± SD.
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incubated with the clarified total cell lysate of WT. Strikingly,
RhlZ-His6 pulled RhlY from the lysate (Figure 5), entailing a
strong and stable RhlY-RhlZ physical interaction.
Taken together, our results indicate that RhlZ is an R-specific
ECH/I, whose activity requires the presence of RhlY with which it
forms a stable complex.
RhlZ-Associated R-Specific Enrichment Is Inhibited by
2-Bromooctanoate
As shown in this study, treating with 2-Br-C8 or inactivating rhlZ
decreases RLs production. In order to verify if RhlZ is one of the
targets of this b-oxidation inhibitor, we added 3 mM 2-Br-C8
directly to ECH assay buffer containing RhlZ in combination
with clarified lysate of WT. Under these conditions, the RhlZ-
associated R-specific enrichment was not inhibited (Figure 4).
However, because previous reports suggested that the active
form of this inhibitor could be one of its metabolites (Raaka
and Lowenstein, 1979), we conducted ECH assays using clari-
fied lysate of WT cells that were cultivated in the presence of
2-Br-C8 (5 mM) and compared this to the control lysate of cells
cultivated in the absence of the inhibitor, both in combination
with purified RhlZ. Using lysate of cells cultivated in the presence
of 2-Br-C8, supposed to contain the active metabolite of this in-
hibitor, the RhlZ-mediated enrichment of the R-isomer was lost
and its abundance approached that when using the control
lysate alone (Figure 4). This indicates that RhlZ is at least partially
inhibited by a 2-bromooctanoate-derived metabolite.
R-3-Hydroxyacyl-CoA Pool Is Shared between RLs and
Polyhydroxyalkanoates Pathways
Because R-3-hydroxyacyl-CoA are also the precursors of
polyhydroxyalkanoates (PHAs) (Madison and Huisman, 1999;160 Chemistry & Biology 21, 156–164, January 16, 2014 ª2014 ElsevWang et al., 2012), we tested the hypothesis that the lipid
precursors supplied by RhlYZ is shared by PHA and RLs.We first
examined the impact of rhlYZ double mutation on the production
of PHA (Figure 6A). Second, we directly assessed PHA produc-
tion by transmission electron microscopy using the percentage
cross-sectional area of intracellular PHA granules (Figures 6B
and 6D). We found a consistent 25% reduction in PHA in the
rhlYZ mutant (Figures 6A and 6B) entailing a shared precursor
pool. Third, we verified if this pool is competitively shared
between PHA and RLs by studying the effect of blocking PHA
biosynthesis on RLs production. To do so, we knocked out
most of PHA-biosynthetic genes, namely DphaC1DC2DFI
(Dpha). This mutation resulted in a remarkable increase in
mono-RL (Rha-C10-C10) accompanied with a small decrease in
di-RL (Rha-Rha-C10-C10) that together resulted in a 13% in-
crease in total RLs compared to the WT (Figure 6C). This is ex-
plained by the accumulation of the shared lipid precursor pool
in the PHA-negative mutant that becomes more available for
RLs biosynthesis. Assuming a fixed rhamnose pool, the con-
sequent high lipid to rhamnose precursors availability, led to
this remarkable doubling in mono-RL congener, of high lipid to
rhamnose content, at the expense of di-RL having lower lipid
to rhamnose content. We thus propose that the fixed rhamnose
precursor pool limited a more striking increase in total RLs.
DISCUSSION
This study unequivocally confirms the implication of b-oxidation
as the main direct metabolic source providing lipidic precursors
for RLs biosynthesis as evidenced by isotope tracing experi-
ments. A previous report suggested that a b-oxidationier Ltd All rights reserved
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Figure 6. RLs and PHA Share the Same 3-Hydroxyalkanoate Pool
(A and B) Deletion of rhlYZ results in a decrease in PHA accumulation, as
estimated by (A) GC-MS analysis of hydrolyzed intracellular 3-hydroxy fatty
acids (C8 to C12) as well as by (B) percentage cross-sectional area of PHA
granules relative to the whole cell cross-sectional area on images taken by
transmission electron microscope, based on an average measurements of
more than 400 cells of both WT and mutant.
(C) The PHA-negative mutant (DphaC1phaDphaC2phaDDphaFDphaI) causes
a slight increase in RLs, mostly with a 100% enrichment of mono-RLs at the
expense of di-RLs.
(D) Thin transmission electron microscope images of PHA granules of
P. aeruginosa PA14 strains; DrhlYZ, WT, Dpha. White spheres are PHA
granules, whereas black spheres are polyphosphates. Magnification bar
represents 100 nm. WT strain and deletion mutants were cultured in MSM-
glycerol for 2–2.5 days at 34C with shaking. Data represent the mean of
triplicate experiments ± SD.
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b-Oxidation Provides Precursors of Rhamnolipidsintermediate (C8) undergoes a one-step elongation by FAS-II to
the corresponding C10 intermediate that is then delivered for
RLs biosynthesis (Zhang et al., 2012). This C2-elongation step
is suggested to be mediated via a FabH-like enzyme that con-
denses acyl-CoA (C8) with malonyl-ACP (Zhang et al., 2012).
Although this model could be contributing, our isotope tracingChemistry & Biology 21, 156data actually show that b-oxidation is still themain direct supplier
of lipid precursors for RLs biosynthesis, with no bypass via
FAS-II. Interestingly, we found that the implication of b-oxidation
in RLs production is constitutive and not only when using
fatty acid carbon sources. This is corroborated by the striking
fact that although a nonfatty acid carbon source is used, specific
inhibition of b-oxidation and/or of b-oxidation-related precursor
diverting enzymes, via 2-bromooctanoic acid, sharply
reduced RLs production. Interestingly, the target inhibited by
2-bromooctanoate seems to be chain length-specific (C6-C8),
as, except for 2-bromohexanoate that is equally effective,
shorter and longer homologs had no remarkable effects on
RLs production. In eukaryotes, 2-bromooctanoate is reported
to irreversibly inhibit FadA of b-oxidation after conversion to 2-
bromo-3-ketooctanoyl-CoA by b-oxidation (Raaka and Lowen-
stein, 1979).
Our mutant-based survey uncovered the channeling route
from b-oxidation toward RLs biosynthesis, in which an enoyl-
CoA intermediate of appropriate chain length (C10), is trans-
formed by enoyl-CoA hydratases/isomerases (ECH/I) rhlK,
rhlY, and rhlZ to the corresponding 3-hydroxyacyl-CoA, that in
turns serves as the lipidic precursors of RLs. This is demon-
strated by the sharp reduction in RLs production in the rhlYZ
mutants, which we attribute to the important reduction (70%)
in the total free 3-hydroxyalkanoates (C10±2), observed in these
mutants. In view of such a decrease, we conclude that RhlYZ
constitutes an axial pathway generating the majority of the
pool of 3-hydroxyalkanoates (C8 and C10) in P. aeruginosa.
Moreover, RhlYZ seems to have a remarkable specificity for
the C10 chain length, and to lesser extents for C8 and C12, as
these 3-hydroxy fatty acids are the most affected in the rhlYZ
mutant. This is in agreement with the fact that the fatty acid
chains of RLs are predominantly (>80%) C10 in P. aeruginosa
(De´ziel et al., 2000).
ECH catalyze the stereospecific hydration of trans-2-enoyl-
CoA, yielding generally S-3-hydroxyacyl-CoA in the second
step of b-oxidation (Bell et al., 2002; Koski et al., 2004), while
a few R-specific-ECH (R-ECH), such as PhaJ1-4 of
P. aeruginosa implicated in PHA synthesis, yield R-3-hydrox-
yacyl-CoA (Tsuge et al., 2003). We found that RhlZ is an
R-ECH that diverts the enoyl-CoA intermediate of b-oxidation
generating the R-3-hydroxyalkanaote precursors required for
RLs, whose 3-hydroxy fatty acid chains are strictly in the
R-configuration (Bauer et al., 2006; Schenk et al., 1997). Our
results indicate that the RhlY forms a complex with RhlZ and is
essential for its activity. We also demonstrated that a metabolite
of 2-bromooctanoate abolishes theR-stereospecificity of RhlYZ,
yet without affecting the net yield of hydration reaction. This se-
lective inhibition suggests that RhlY is exerting a classic S-ECH
role, while RhlZ has an R-isomerase role in the RhlYZ complex
and that it is RhlZ, and not RhlY, that is inhibited by the metabo-
lite of 2-bromooctanoate.
The 3-hydroxyalkanoate pool generated by RhlYZ is not only
devoted to RLs, but also partly used for PHA synthesis whose
precursors are CoA-activated R-3-hydroxy fatty acids (Wang
et al., 2012). While we expected a more significant increase in
RLs production in a PHA-negative mutant, because of the accu-
mulation of lipid precursors, we believe that the limited rhamnose
pool hindered a net increase in RLs. As a result, the effect of lipid–164, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 161
Figure 7. Proposed Model for Metabolic Supply of Lipid Precursors of RLs
With a fatty acid carbon source, shortening of the chain takes place by b-oxidation until the formation of the trans-2-decenoyl-CoA intermediate. With a soluble
carbon source like glycerol, de novo synthesis of fatty acids via FAS-II forms fatty acids that are proposed to be diverted to b-oxidation to be processed into the
trans-2-decenoyl-CoA intermediate. In either case, the trans-2-decenoyl-CoA is hydrated by the R-specific enoyl-CoA hydratase RhlYZ to form R-3-hydrox-
ydecanoyl-CoA, which then acts as the direct lipid precursors used by RhlA for the synthesis of HAAs, which is then converted by RhlB and RhlC into RLs.
Although clearly less significant, a direct precursor supply from FAS-II could also be contributing in RLs biosynthesis. PHAs share with RLs the same pool of R-3-
hydroxyacyl-CoA. FabB and FabF, 3-ketoacyl-ACP synthetases; FabG, NADPH-dependent 3-ketoacyl-ACP reductase; FabA, FabZ, 3-hydroxyacyl-ACP de-
hydratases; FabI, NADH-dependent enoyl-ACP reductase; FadD, acyl-CoA synthetase; FadE, acyl-CoA dehydrogenase; FadB, trans-enoyl-CoA hydratase and
S-3-hydrxoyacyl-CoA dehydrogenase; FadA, 3-ketoacyl-CoA thiolase; RhlA, HAA synthetase; RhlB, rhamnosyltransferase 1; RhlC, rhamnosyltransferase 2.
See also Figures S3–S5.
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b-Oxidation Provides Precursors of Rhamnolipidsaccumulation together with a limited rhamnose pool reflected
on the increased ratio of mono-RLs to di-RLs upon inactivation
of PHA synthesis. Strictly regulated availability of dTDP-L-rham-
nose is expected, as the genes coding for the enzymes respon-
sible for its biosynthesis are regulated by quorum sensing, along
with rhlAB and rhlC (Aguirre-Ramı´rez et al., 2012). Interestingly,
RhlYZ was also reported to be regulated by quorum sensing
(Wagner et al., 2007), entailing that RLs biosynthesis is tightly
regulated by quorum sensing to synchronize the expression of
the terminal-linking enzymes rhlABC with precursors supply,
rhamnose, and fatty acids.
We propose a model in which acyl-CoA (substrate-derived or
de novo synthesized) enters b-oxidation for shortening, and
chains of appropriate lengths (C10) are then diverted by the
action of RhlYZ to RLs biosynthesis, with PHA biosynthesis
pathway sharing the same lipid precursors (Figure 7). Additional
work is still required to elucidate the mechanism linking de novo
fatty acid synthesis and b-oxidation when using nonfatty acid
carbon sources. This link could reveal an important regulatory
mechanism of lipid metabolism, where de novo synthesized
lipids delivered by FAS-II are reserved for primary cell structures162 Chemistry & Biology 21, 156–164, January 16, 2014 ª2014 Elsevand metabolism, whereas lipid precursors destined for extracel-
lular secondary metabolites like RLs are instead provided via the
b-oxidation pathway, such as by R-ECH like rhlYZ that is coregu-
lated with rhlAB and rmlBDAC. This compartmentalization of
lipid precursors is thought to be a regulatory mechanism pre-
venting secondary metabolism from competing with primary
metabolism for the same central precursors.
These findings will have a great impact on the metabolic
engineering strategies aiming at enhancing RLs production. In
general terms, our results show that not only rhlABC genes are
important to be targeted in metabolic engineering strategies
but also genes supplying metabolic precursors. Moreover, our
findings suggest that fatty acid carbon sources are better than
the soluble ones, as the former would be directly incorporated
in the lipid chains of RLs after a bypass in b-oxidation, whereas
the latter requires a longer de novo metabolic synthesis of lipid
precursors. On the other hand, glycerol as carbon source is
more metabolically proximal than fatty acids to the rhamnose
biosynthetic pathway (Abdel-Mawgoudet al., 2011) as fatty acids
require the longer pathway of gluconeogenesis for synthesis of
this precursor. Taken together, our observations finally explainier Ltd All rights reserved
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(i.e., glycerol and fatty acids), represent by far the best carbon
source for the highest yield of RLs (Mu¨ller et al., 2012) as they
generate the metabolically optimal cocarbon sources for rham-
nose and 3-hydroxyalkanoate precursors biosynthesis.
SIGNIFICANCE
Rhamnolipids (RLs) are bacterial surfactants of biotechno-
logical importance principally produced by Pseudomonas
aeruginosa. Currently, there is lack of understanding of the
definitive metabolic origin of the two precursors of RLs,
namely, the sugar, rhamnose, and the lipid chain, 3-hydrox-
yalkanaote. In this study, we demonstrate that b-oxidation is
the main direct suppliers of lipid precursors of RLs. We
found that the shunting mechanism of b-oxidation interme-
diates to RLs biosynthesis is mediated by an R-specific
enoyl-CoA hydratase complex RhlYZ. This complex diverts
enoyl-CoA intermediates of b-oxidation into R-3-
hydroxyalkanoates that acts as lipid precursors of RLs. It
is found that RhlYZ is responsible for 70% of the total
pool of 3-hydroxyalkanoates in P. aeruginosa PA14. The
RhlYZ-generated pool of 3-hydroxyalkanoates serves as
precursors for not only RLs but also for polyhydroxyalka-
noates granules synthesis, another secondary metabolite
produced by P. aeruginosa. Findings of this work decipher
an axial pathway, mediated by RhlYZ, linking primary lipid
metabolism with RLs biosynthesis and with secondary
metabolism in general. These findings enhance the under-
standing of RLs biosynthesis and provide the foundations
for futuremetabolic engineering strategies aiming at scaling
up RLs production.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
Bacterial strains and plasmids are described in Table S1.
Seed cultures of P. aeruginosa PA14 in tryptic soy broth (TSB; Difco) incu-
bated overnight at 37C under rotation were used to inoculate mineral salts
medium (MSM) at a starting OD600 of 0.1. MSM has the following composition:
Na2HPO4 (0.9 g/l), KH2PO4 (0.7 g/l), CaCl2 3 2H2O (0.1 g/l), MgSO4 3 7H2O
(0.4 g/l), NaNO3 (2 g/l), tryptone (1 g/l), trace element solution (TES, 2 ml/l),
pH adjusted to 7. Composition of TES is: FeSO4 3 7H2O (2 g/l), MnSO4 3
H2O (1.5 g/l), (NH4)6Mo7O24 3 4H2O (0.6 g/l). Glycerol (20 g/l) was used as
the carbon source unless otherwise stated. Tryptone was omitted when fatty
acid carbon sources were tested. Inoculated MSM medium was incubated
at 34C under rotation.
P. aeruginosa was grown on LB agar (NaCl 5 g/l) at 37C for mating
purposes and for selection of transformants after mating or electroporation.
It was also grown in LB-no salt (LBNS, with no NaCl) broth at 30C for reso-
lution ofmerodiploids inmutant constructions. Antibiotics were added tomain-
tain or select for plasmids as follows: for Escherichia coli, carbenicillin (Cb) at
100 mg/ml, gentamicin (Gm) at 30 mg/ml, tetracycline (Tc) at 15 mg/ml, kana-
mycin (Km) at 50 mg/ml; for P. aeruginosa, carbenicillin (Cb) at 300 mg/ml,
Gm at 50 mg/ml, and Tc at 125 mg/ml for solid media and at 75 mg/ml for liquid
media. Triclosan, at 10 mg/ml, was used to counter select E. coli.
Gene Mutation and Cloning
Deletions mutants were generated via homologous allelic replacement using
Gateway technology (Choi and Schweizer, 2005). For rhlZ overexpression
and complementation studies, the coding sequence, including its natural
ribosomal binding site, was cloned onto pUCP26. For protein purification,
rhlY and rhlZ were cloned downstream to coding sequence for the His-TagChemistry & Biology 21, 156onto pET28a plasmids. Full details are described in the Supplemental Exper-
imental Procedures.
Protein Expression, Purification, and Preparation of Crude Cell
Lysates
The expression of recombinant RhlZ or RhlY proteins with an N-terminal
6xHis-tag encoded by pET28a(+)-rhlZ was induced with 0.5 mM isopropyl-
1-thio-D-galactopyranoside (IPTG) in a fresh subculture (starting OD600 of
0.05) of E. coli BL21(DE3) when the OD600 = 0.8. Incubation was then
continued at 34C under rotation of 150 rpm for 2–3 hr. Cells were then
collected by centrifugation, resuspended in the binding buffer (20 mM
NaPO4, pH 7.4, 500 mM NaCl, 25 mM imidazole, 20 mM b-mercaptoethanol)
freshly supplemented with Mini Protease Inhibitor Cocktail Tablets (Roche)
and 0.5 mM phenylmethanesulfonylfluoride (PMSF), and lysed by sonication
for nine cycles each of 30 s interrupted by 30 s of rest on ice. Each cell
lysates were clarified by centrifugation at 10,000 3 g at 4C for 30–45 min
and then applied onto a preconditioned Ni Sepharose High Performance col-
umn (HisTrapHP-5ml, GE) using fast protein liquid chromatography (AKTA
FPLC, GE). Preconditioning of the column was achieved according to instruc-
tions of the manufacturer and flow rate was adjusted at 5 ml/min. The column
was washed with five column volumes of binding buffer then a linear gradient
was initiated. For RhlZ purification, the gradient was from 0% to 50% elution
buffer (20 mM NaPO4, pH 7.4, 500 mM NaCl, 500 mM imidazole, 20 mM
b-mercaptoethanol) over 20 column volumes. For RhlY, the gradient was
from 0% to 100% elution buffer over 30 column volumes. Fractions of 5 ml
were collected throughout the chromatography. RhlZ started to elute out of
the column at 130 mM, peaked at 160 mM and tailed at 190 mM imidazole
(Figure S7A), RhlY started to elute at 170 mM, peaked at 240 mM and tailed
at 335 mM imidazole (Figure S7B). Fractions of these peaks and flanking
fractions were applied to 12% (w/v) sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) (Figure S7). Appearing bands were excised
for identification via protein sequencing at the Proteomic services of INRS-
Institut Armand Frappier (Canada). Fractions containing pure proteins were
pooled together and concentrated with Amicon Ultra-15 (30 kDa, Millipore)
for RhlZ and Amicon Ultra-15 (15 kDa) for RhlY, and washed with 900 volumes
of buffer (50 mM Tris-Cl, pH 7.7, 1 mM EDTA, 10 mM b-mercaptoethanol,
0.5 mM PMSF). The Amicon-concentrated protein solutions were assayed
using Bradford method (protein concentration was 8 mg/ml), then aliquoted
and stored at 80C. Intact protein masses were determined by mass
spectrometry (Quattro Premier XE, Micromass) equipped with an electrospray
ionization interface at the positive mode using direct infusion of purified
proteins at 800 mg/l that were diluted and washed in 50 mM ammonium
carbonate solution. The obtained spectra were integrated using the MaxEnt
1 option of MassLynx software. Intact masses of purified proteins were
31,933 and 42,648 Da positively identifying the proteins as His-tagged RhlY
and RhlZ, respectively, both lacking their N-terminal fMet amino acid.
Clarified cell lysate of WT PA14 strain and of the mutants DrhlZ and DrhlYZ
were prepared similarly from cells collected from a 25 ml fresh culture in TSB
broth that were then washed and sonicated in lysis buffer (50 mM Tris-Cl,
pH 7.7, 1 mM EDTA, 10 mM b-mercaptoethanol, 0.5 mM PMSF) (Davis
et al., 2008) to be used fresh or kept at 4C until use.
Synthesis of trans-2-Decenoyl-CoA and Chiral HPLC-MS/MS Assay
of Hydratase
trans-2-Decenoyl-Co was synthesized using the mixed anhydride method
(Abdel-Mawgoud et al., 2013).
An amount of 2–4 mg of pure enzyme and/or 20 ml of clarified cell lysates was
used for the activity assays. Enzymatic reaction set up and enzyme product
assay using chiral HPLC-MS/MS were conducted as described by Abdel-
Mawgoud et al. (2013).
Chromatographic Analysis of Rhamnolipids, 3-Hydroxy Fatty Acids,
and PHA
RLs were analyzed using an HPLC coupled with MS/MS as described
previously (De´ziel et al., 1999). 3-Hydroxy fatty acids were analyzed using
gas chromatography-mass spectrometry (GC/MS). PHA was analyzed by
the GC/MS estimation of 3-hydroxy fatty acids pool as well as by estimation
of the trans-sectional area of PHA granules as visualized by transmission–164, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 163
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b-Oxidation Provides Precursors of Rhamnolipidselectron microscope. Full details are described in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2013.11.010.
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